{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:23:43Z","timestamp":1775489023554,"version":"3.50.1"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Skin cutaneous malignant melanoma (SKCM) is among the most aggressive forms of skin cancer, notorious for its rapid progression and poor prognosis under late diagnosis. This study investigates the role of circadian rhythm-related genes (CRGs) in SKCM addressing a gap in understanding how CRGs affect tumor progression and patient outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An analysis of CRGs expression was conducted on SKCM samples derived from The Cancer Genome Atlas datasets(TCGA). Moreover, a correlation between various subtypes and their clinical features was identified. The study employed various bioinformatics methods, including differential expression analysis, consensus clustering, and survival analysis, to investigate the role of CRGs. The functional consequences of various CRG expression patterns were further investigated using immune infiltration analysis and gene set variation analysis (GSVA). A scoring system based on CRGs was developed to predict overall survival (OS) and treatment responses in SKCM patients. The predictive accuracy of this score system was then tested, and a nomogram was used to improve its clinical usefulness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Key findings from this study include significant genetic alterations in circadian rhythm-related genes (CRGs) in skin cutaneous melanoma (SKCM), such as mutations and CNVs. Two molecular subtypes with distinct clinical outcomes and immune profiles were identified. A prognostic model based on six CRGs (<jats:italic>CMTM<\/jats:italic>, <jats:italic>TNPO1<\/jats:italic>, <jats:italic>CTBS<\/jats:italic>, <jats:italic>UTRN<\/jats:italic>, <jats:italic>HK2<\/jats:italic>, and <jats:italic>LIF<\/jats:italic>) was developed and validated with TCGA and GEO datasets, showing high predictive accuracy for overall survival (OS). A high CRGs score correlated with poor OS, immune checkpoint expression, and reduced sensitivity to several chemotherapeutics, including AKT inhibitor VIII and Camptothecin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This work provides valuable insights into the circadian regulation of SKCM and underscores the potential of CRGs as biomarkers for prognosis and targets for therapeutic interventions. The novel molecular subtypes and CRGs prognostic scoring model introduced in this study offer significant contributions to the understanding and management of SKCM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1513750","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:21:20Z","timestamp":1742534480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Circadian rhythm related genes identified through tumorigenesis and immune infiltration-guided strategies as predictors of prognosis, immunotherapy response, and candidate drugs in skin cutaneous malignant melanoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Chengling","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiming","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.8023","article-title":"Overall survival in patients with advanced melanoma who received nivolumab versus investigator\u2019s choice chemotherapy in checkMate 037: A randomized, controlled, open-label phase III trial","volume":"36","author":"Larkin","year":"2018","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of advanced melanoma in 2020 and beyond","volume":"141","author":"Jenkins","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat8806","article-title":"A database of tissue-specific rhythmically expressed human genes has potential applications in circadian medicine","volume":"10","author":"Ruben","year":"2018","journal-title":"Sci Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature25170","article-title":"Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence","volume":"553","author":"Sulli","year":"2018","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.07.001","article-title":"Circadian rhythm disruption promotes lung tumorigenesis","volume":"24","author":"Papagiannakopoulos","year":"2016","journal-title":"Cell Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213722","article-title":"Circadian disruption and consequences on innate immunity and inflammatory response","volume":"23","author":"Jerigova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4957996","article-title":"Dysregulation of circadian clock genes associated with tumor immunity and prognosis in patients with colon cancer","volume":"2022","author":"He","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-1904-2","article-title":"Running for time: circadian rhythms and melanoma","volume":"35","author":"Markova-Car","year":"2014","journal-title":"Tumour Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.042","article-title":"The cancer genome atlas: creating lasting value beyond its data","volume":"173","author":"Hutter","year":"2018","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","year":"2015","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3655","article-title":"Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy","volume":"6","author":"Cirenajwis","year":"2015","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.777724","article-title":"Identification of a novel nomogram to predict progression based on the circadian clock and insights into the tumor immune microenvironment in prostate cancer","volume":"13","author":"Feng","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2430","article-title":"The genetics of mammalian circadian order and disorder: implications for physiology and disease","volume":"9","author":"Takahashi","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"20241014","DOI":"10.1515\/med-2024-1014","article-title":"Exploring anesthetic-induced gene expression changes and immune cell dynamics in atrial tissue post-coronary artery bypass graft surgery","volume":"19","author":"Bao","year":"2024","journal-title":"Open Med (Wars)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1179","article-title":"Gene Ontology Consortium: going forward","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2721005","article-title":"Deciphering a novel necroptosis-related miRNA signature for predicting the prognosis of clear cell renal carcinoma","volume":"2022","author":"Bao","year":"2022","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41592-019-0486-8","article-title":"Expanded CIBERSORTx","volume":"16","author":"Rusk","year":"2019","journal-title":"Nat Methods"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"SChadendorf","year":"2018","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"168","author":"Hugo","year":"2017","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115249108","article-title":"Control of skin cancer by the circadian rhythm","volume":"108","author":"Gaddameedhi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1021\/bi5007354","article-title":"Circadian clock, cancer, and chemotherapy","volume":"54","author":"Sancar","year":"2015","journal-title":"Biochemistry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0092-8674(02)00961-3","article-title":"The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo","volume":"111","author":"Fu","year":"2002","journal-title":"Cell"},{"key":"B46","article-title":"Marked 24-h rest\/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status","volume":"6","author":"Mormont","year":"2000","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41573-020-00109-w","article-title":"Circadian rhythm as a therapeutic target","volume":"20","author":"Ruan","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.09.004","article-title":"Human epidermal stem cell function is regulated by circadian oscillations","volume":"13","author":"Janich","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10555-022-10072-0","article-title":"Circadian disruption: from mouse models to molecular mechanisms and cancer therapeutic targets","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/php.12662","article-title":"Impact of the circadian clock on UV-induced DNA damage response and photocarcinogenesis","volume":"93","author":"Dakup","year":"2017","journal-title":"Photochem Photobiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00136","article-title":"Desynchronization of circadian clocks in cancer: A metabolic and epigenetic connection","volume":"8","author":"Padmanabhan","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.917776","article-title":"High expression of TIMELESS predicts poor prognosis: A potential therapeutic target for skin cutaneous melanoma","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-021-02725-5","article-title":"Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility","volume":"19","author":"Benna","year":"2021","journal-title":"J Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.09.014","article-title":"Quantitative assessment of CMTM6 in the tumor microenvironment and association with response to PD-1 pathway blockade in advanced-stage non-small cell lung cancer","volume":"14","author":"Zugazagoitia","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7150\/jca.93733","article-title":"CMTM6: A critical prognostic indicator in non-small cell lung cancer","volume":"15","author":"Dai","year":"2024","journal-title":"J Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03171-y","article-title":"CMTM6 as a master regulator of PD-L1","volume":"71","author":"Yaseen","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001638","article-title":"CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer","volume":"9","author":"Peng","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221147566","article-title":"Tastin promotes non-small-cell lung cancer progression through the ErbB4, PI3K\/AKT, and ERK1\/2 pathways","volume":"248","author":"Yue","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33832","article-title":"Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers","volume":"150","author":"van der Watt","year":"2022","journal-title":"Int J Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2021.05.016","article-title":"TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer","volume":"515","author":"Yang","year":"2021","journal-title":"Cancer Lett"},{"key":"B64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-022-01615-8","article-title":"CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p","volume":"21","author":"Xi","year":"2022","journal-title":"Mol Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.239","article-title":"SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I\/\u03b12\u03b21 integrin axis","volume":"131","author":"Girotti","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1563","article-title":"Hexokinase 2 as oncotarget","volume":"4","author":"Patra","year":"2013","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1849","article-title":"SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia","volume":"12","author":"Wei","year":"2022","journal-title":"Cancer Discovery"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/930509","article-title":"Linking ER stress to autophagy: potential implications for cancer therapy","volume":"2010","author":"Verfaillie","year":"2010","journal-title":"Int J Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1191217","article-title":"Neratinib, a pan ERBB\/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF\/MEK inhibition","volume":"14","author":"DuBose","year":"2024","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/13880209.2023.2200787","article-title":"Sanguinarine inhibits melanoma invasion and migration by targeting the FAK\/PI3K\/AKT\/mTOR signalling pathway","volume":"61","author":"Qi","year":"2023","journal-title":"Pharm Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2378","article-title":"Exiting the golgi complex","volume":"9","author":"De Matteis","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1663","article-title":"Preventing re-replication of chromosomal DNA","volume":"6","author":"Blow","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-024-01280-z","article-title":"Unwinding of a eukaryotic origin of replication visualized by cryo-EM","volume":"31","author":"Henrikus","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrd3056","article-title":"Seven-transmembrane receptors: One way only","volume":"8","author":"Harrison","year":"2009","journal-title":"Nat Rev Drug Discovery"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0100-y","article-title":"Navigating the nuances of clinical sequence variant interpretation in Mendelian disease","volume":"20","author":"Strande","year":"2018","journal-title":"Genet Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","article-title":"A pan-cancer single-cell panorama of human natural killer cells","volume":"186","author":"Tang","year":"2023","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"10633","DOI":"10.1038\/s41598-019-46919-w","article-title":"Risk factors before dialysis predominate as mortality predictors in diabetic maintenance dialysis patients","volume":"9","author":"Tsur","year":"2019","journal-title":"Sci Rep"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e007144","DOI":"10.1136\/jitc-2023-007144","article-title":"Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies","volume":"11","author":"Adegoke","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e175706","DOI":"10.1172\/JCI175706","article-title":"Circadian immunity from bench to bedside: a practical guide","volume":"134","author":"Mok","year":"2024","journal-title":"J Clin Invest"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700431","article-title":"The circadian clock protein BMAL1 acts as a metabolic sensor in macrophages to control the production of pro IL-1\u03b2","volume":"12","author":"Timmons","year":"2021","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02451","article-title":"Pan-cancer analysis reveals disrupted circadian clock associates with T cell exhaustion","volume":"10","author":"Wu","year":"2019","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-83","article-title":"Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma","volume":"13","author":"Lassen","year":"2014","journal-title":"Mol Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184581","article-title":"Mesenchymal chondrosarcoma from diagnosis to clinical trials","volume":"15","author":"Dudzisz-\u015aled\u017a","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113716","article-title":"RJT-101, a novel camptothecin derivative, is highly effective in the treatment of melanoma through DNA damage by targeting topoisomerase 1","volume":"171","author":"Lian","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/09553009414550941","article-title":"Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines","volume":"66","author":"Ng","year":"1994","journal-title":"Int J Radiat Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00008390-199402000-00002","article-title":"Therapeutic efficacy of camptothecin derivatives against human Malignant melanoma xenografts","volume":"4","author":"Pantazis","year":"1994","journal-title":"Melanoma Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/nar\/gkv1221","article-title":"Bioinformatic tools for microRNA dissection","volume":"44","author":"Akhtar","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"15786","DOI":"10.1038\/s41598-024-65928-y","article-title":"Novel liquid biopsy CNV biomarkers in Malignant melanoma","volume":"14","author":"Lukacova","year":"2024","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e13210","DOI":"10.1111\/pcmr.13210","article-title":"Exploring the common mutational landscape in cutaneous melanoma and pancreatic cancer","volume":"38","author":"Broseghini","year":"2025","journal-title":"Pigment Cell Melanoma Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001032","article-title":"Single-nucleotide polymorphisms in the p53 signaling pathway","volume":"2","author":"Grochola","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2174\/187152010794474019","article-title":"Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents","volume":"10","author":"Lee","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1513750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:21:25Z","timestamp":1742534485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1513750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":95,"alternative-id":["10.3389\/fimmu.2025.1513750"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1513750","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"article-number":"1513750"}}